These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28575522)

  • 1. Identification of biomarker sets for predicting the efficacy of sublingual immunotherapy against pollen-induced allergic rhinitis.
    Gotoh M; Kaminuma O; Nakaya A; Katayama K; Motoi Y; Watanabe N; Saeki M; Nishimura T; Kitamura N; Yamaoka K; Okubo K; Hiroi T
    Int Immunol; 2017 Jun; 29(6):291-300. PubMed ID: 28575522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Relationship of Pollen Dispersal with Allergy Symptoms and Immunotherapy: Allergen Immunotherapy Improves Symptoms in the Late Period of Japanese Cedar Pollen Dispersal.
    Sakurai T; Yonekura S; Iinuma T; Sakurai D; Morimoto Y; Kaneko S; Okamoto Y
    Int Arch Allergy Immunol; 2018; 177(3):245-254. PubMed ID: 30021201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictivity of clinical efficacy of sublingual immunotherapy (SLIT) based on sensitisation pattern to molecular allergens in children with allergic rhinoconjunctivitis.
    di Coste A; Occasi F; De Castro G; Zicari AM; Galandrini R; Giuffrida A; Indinnimeo L; Duse M
    Allergol Immunopathol (Madr); 2017; 45(5):452-456. PubMed ID: 28410874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological effects of sublingual immunotherapy with Japanese cedar pollen extract in patients with combined Japanese cedar and Japanese cypress pollinosis.
    Kikuoka H; Kouzaki H; Matsumoto K; Arai H; Yamamoto S; Tojima I; Shimizu S; Miyashita H; Ogawa Y; Osada T; Okano M; Yuta A; Shimizu T
    Clin Immunol; 2020 Jan; 210():108310. PubMed ID: 31743749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent development on the use of sublingual immunotherapy tablets for allergic rhinitis.
    Waserman S; Shah A; Avilla E
    Ann Allergy Asthma Immunol; 2021 Aug; 127(2):165-175.e1. PubMed ID: 34029713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term sublingual immunotherapy for Japanese cedar pollinosis and the levels of IL-17A and complement components 3a and 5a.
    Sakashita M; Yamada T; Imoto Y; Hirota T; Tamari M; Ito Y; Kubo S; Osawa Y; Takahashi N; Fujieda S
    Cytokine; 2015 Sep; 75(1):181-5. PubMed ID: 25934649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublingual immunotherapy alters salivary IgA and systemic immune mediators in timothy allergic children.
    Huoman J; Papapavlou G; Pap A; Alm J; Nilsson LJ; Jenmalm MC
    Pediatr Allergy Immunol; 2019 Aug; 30(5):522-530. PubMed ID: 30803044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis.
    Okamoto Y; Okubo K; Yonekura S; Hashiguchi K; Goto M; Otsuka T; Murata T; Nakao Y; Kanazawa C; Nagakura H; Okawa T; Nakano K; Hisamitsu M; Kaneko S; Konno A
    Int Arch Allergy Immunol; 2015; 166(3):177-88. PubMed ID: 25895909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Efficacy and Dose-Finding Trial of Japanese Cedar Pollen Sublingual Immunotherapy Tablet.
    Gotoh M; Yonekura S; Imai T; Kaneko S; Horikawa E; Konno A; Okamoto Y; Okubo K
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1287-1297.e8. PubMed ID: 30537561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Japanese cedar-specific sublingual immunotherapy on allergen-specific TH2 cell counts in blood.
    Nomura T; Suzuki M; Yokota M; Nakamura Y; Ozeki K; Ito Y; Tsuge I; Saitoh S
    Ann Allergy Asthma Immunol; 2016 Jul; 117(1):72-78.e4. PubMed ID: 27156747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term sublingual immunotherapy provides better effects for patients with Japanese cedar pollinosis.
    Hamada S; Kobayashi Y; Sakamoto D; Shimamura A; Kuroda K; Kawachi R; Kanda A; Asako M; Gotoh M; Okubo K; Tomoda K; Iwai H
    Auris Nasus Larynx; 2021 Aug; 48(4):646-652. PubMed ID: 33526319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
    Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Yamamoto H; Kunii N; Sakurai D; Fujimura T; Nakazawa K; Yasueda H
    Int Arch Allergy Immunol; 2008; 146(1):76-84. PubMed ID: 18087165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of factors related to the effect of sublingual immunotherapy on Japanese cedar pollen induced allergic rhinitis.
    Yonekura S; Okamoto Y; Sakurai D; Okubo K; Gotoh M; Kaneko S; Konno A
    Allergol Int; 2018 Apr; 67(2):201-208. PubMed ID: 28760534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological parameters in prophylactic sublingual immunotherapy in asymptomatic subjects sensitized to Japanese cedar pollen.
    Yamanaka K; Shah SA; Sakaida H; Yamagiwa A; Masuda S; Mizutani H; Takeuchi K
    Allergol Int; 2015 Jan; 64(1):54-9. PubMed ID: 25605528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety evaluation of standardized allergen extract of Japanese cedar pollen for sublingual immunotherapy.
    Mitobe Y; Yokomoto Y; Ohashi-Doi K
    Regul Toxicol Pharmacol; 2015 Apr; 71(3):529-40. PubMed ID: 25701184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment of Japanese cedar pollinosis with Japanese cedar pollen SLIT drops and persistence of treatment effect: A post-marketing clinical trial.
    Nomura Y; Okubo K; Nakamura T; Sawaki S; Kitagou H; Idei N; Kaneko S; Kobayashi S; Tanaka Y; Okamoto Y
    Allergol Int; 2021 Jan; 70(1):96-104. PubMed ID: 32653209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Japanese cedar pollen sublingual immunotherapy is effective in treating seasonal allergic rhinitis during the pollen dispersal period for Japanese cedar and Japanese cypress.
    Yonekura S; Gotoh M; Okano M; Kurokawa T; Maekawa Y; Okubo K; Okamoto Y
    Allergol Int; 2022 Jan; 71(1):140-143. PubMed ID: 34509370
    [No Abstract]   [Full Text] [Related]  

  • 18. The Efficacy of Sublingual Immunotherapy for Allergic Rhinitis May Vary with the Time of Day.
    Igarashi S; Suzuki K; Nakamura Y; Ishimaru K; Fukano C; Masuyama K; Ohashi-Doi K; Nakao A
    Int Arch Allergy Immunol; 2016; 171(2):111-118. PubMed ID: 27902978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From the genesis to the present: The evolution of sublingual immunotherapy for cedar pollinosis.
    Gotoh M; Kaminuma O; Okubo K
    Allergol Int; 2024 Oct; 73(4):494-500. PubMed ID: 39043490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-finding study of carbamylated monomeric allergoid tablets in grass-allergic rhinoconjunctivitis patients.
    Mösges R; Rohdenburg C; Eichel A; Zadoyan G; Kasche EM; Shah-Hosseini K; Lehmacher W; Schmalz P; Compalati E
    Immunotherapy; 2017 Nov; 9(15):1225-1238. PubMed ID: 29130797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.